The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 73-85

  Ben Batalla, I ^a   Seoane, S ^a   Macia, M ^a   Garcia Caballero, T ^a   Gonzalez, L O ^b   Vizoso, F ^b   Perez Fernandez, R ^a  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL DE JOVE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROLACTIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PIT 1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CELL LINE, TUMOR; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; NIH 3T3 CELLS; PROLACTIN; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION, GENETIC;

EID: 77449085556     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0100     Document Type: Article

References (39)

1. Bamberger AM, Bamberger CM, Pu LP, Puy LA, Loh YP & Asa SL 1995 Expression of Pit-1 messenger ribonucleic acid and protein in the human placenta. Journal of Clinical Endocrinology and Metabolism 80 2021-2026.
2. Ben-Jonathan N, Liby K, McFarland M & Zinger M 2002 Prolactin as an autocrine/paracrine growth factor in human cancer. Trends in Endocrinology and Metabolism 13 245-250.
3. Berwaer M, Martial JA & Davis JRE 1994 Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Molecular Endocrinology 8 635-642.
4. Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Gosh N & Trivedi TI 2000a Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis. Annals of Surgical Oncology 7 305-311.
5. Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, Chikhlikar PR & Trivedi TI 2000b Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. European Journal of Surgical Oncology 26 540-547.
6. Brockman JL, Schroeder MD & Schuler LA 2002 PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Molecular Endocrinology 16 774-784.
7. Castrillo JL, Theill L & Karin M 1991 Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253 97-199.
8. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT & Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. American Journal of Pathology 146 695-705.
9. Clevenger CV, Furth PA, Hankinson SE & Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocrine Reviews 24 1-27.
10. Dagvadorj A, Collins S, Jomain J-B, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T et al. 2007 Autocrine prolactin promotes prostate cancer cell growth via janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 148 3089-3101.
11. Delhase M, Vergani P, Malur A, Hooghe-Peters EL & Hooghe RJ 1993 The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. European Journal of Immunology 23 951-955.
12. Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80 1523-1631.
13. Fuh G & Wells JA 1995 Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. Journal of Biological Chemistry 270 13133-13137.
14. Gaiddon C, de Tapia M & Loeffler JP 1999 The tissue-specific transcription factor Pit-1/GHF-1 binds to the c-fos serum response element and activates c-fos transcription. Molecular Endocrinology 13 742-751.
15. Gellersen B, Kempf R, Telgmann R & DiMattia GE 1994 Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Molecular Endocrinology 8 356-373.
16. Gellersen B, Kempf R, Telgmann R & DiMattia GE 1995 Pituitary-type transcription of the human prolactin gene in the absence of Pit-1. Molecular Endocrinology 9 887-901.
17. Gil-Puig C, Blanco M, Garcia-Caballero T, Segura C & Perez-Fernandez R 2002 Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line. Journal of Endocrinology 173 161-167.
18. Gil-Puig C, Seoane S, BlancoM,MaciaM,Garcia-CaballeroT, Segura C & Perez-Fernandez R 2005 Pit-1 is expressed in normal and tumoral human breast and regulates growth hormone secretion and cell proliferation. European Journal of Endocrinology 153 335-344.
19. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
20. Kurotani R, Yoshimura S, Iwasaki Y, Inoue K, Teramoto A & Osamura RY 2002 Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. Journal of Endocrinology 172 477-487.
21. Lee EJ, Russell T, Hurley L & Jameson JL 2005 Pituitary transcription factor-1 induces transient differentiation of adult hepatic stem cells into prolactin-producing cells in vivo. Molecular Endocrinology 19 964-971.
22. Lefevre C, Imagawa M, Dana S, Grindlay J, Bodner M & Karin M 1987 Tissue specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO Journal 6 971-981.
23. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW & Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 347 528-533.
24. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA & Goffin V 2000 Human prolactin (hPRL) antagonists inhibit hPRL-activated signalling pathways involved in breast cancer cell proliferation. Oncogene 19 4695-4705.
25. Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA & Muller M 2005 EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element. Molecular and Cellular Endocrinology 229 127-139.
26. Markoff E & Lee DW 1987 Glycosylated prolactin is a major circulating variant in human serum. Journal of Clinical Endocrinology and Metabolism 65 1102-1106.
27. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE & Morel G 1998 Cellular expression of growth hormone and prolactin receptors in human breast disorders. International Journal of Cancer 79 202-211.
28. Nelson C, Albert VR, Elsholtz HP, LI-W Lu & Rosenfeld MG 1988 Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239 1400-1405.
29. Peers B, Monget P, Nalda A, Voz ML, Berwaer M, Belayew A &Martial JA 1991 Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1. Journal of Biological Chemistry 266 18127-18134.
30. Seoane S & Perez-Fernandez R 2006 The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor. Molecular Endocrinology 20 735-748.
31. Seoane S, Ben I, Centeno V & Perez-Fernandez R 2007 Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1. Molecular Endocrinology 21 1513-1525.
32. Shaw-Bruha CM, Pirrucello SJ & Shull JD 1997 Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Research and Treatment 44 243-253.
33. Shinha YN 1995 Structural variants of prolactin: occurrence and physiological significance. Endocrine Reviews 16 354-369.
34. Tworoger SS, Eliassen AH, Sluss P & Hankinson SE 2007 A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. Journal of Clinical Oncology 25 1482-1488.
35. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocrine-Related Cancer 6 389-404.
36. Voss JW, Yao T-P & Rosenfeld MG 1991 Alternative translation initiation site usage results in two structurally distinct forms of Pit-1. Journal of Biological Chemistry 266 12832-12835.
37. Welsch CW & Nagasawa H 1977 Prolactin and murine mammary tumorogenesis: a review. Cancer Research 37 951-963.
38. Wennbo H & Törnell J 2000 The role of prolactin and growth hormone in breast cancer. Oncogene 19 2744-2751.
39. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG & Tornell J 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. Journal of Clinical Investigation 100 2744-2751.